The global Sentinel Node Biopsy Market is witnessing steady growth due to increasing cancer diagnosis rates, rising adoption of minimally invasive surgical procedures, and growing awareness regarding early-stage cancer detection. Sentinel node biopsy procedures are widely used in oncology to determine cancer spread while minimizing unnecessary lymph node removal. Increasing adoption of advanced imaging agents, diagnostic kits, and surgical instruments is further supporting market expansion.

According to Fortune Business Insights, the global Sentinel Node Biopsy Market was valued at USD 833.93 million in 2025 and is projected to grow from USD 893.25 million in 2026 to USD 1,547.83 million by 2034, exhibiting a CAGR of 7.11% during the forecast period.

Why is the Sentinel Node Biopsy Market Growing Rapidly?

Sentinel node biopsy plays an important role in cancer staging by helping physicians determine whether cancer cells have spread to nearby lymph nodes. The increasing prevalence of breast cancer and melanoma, combined with growing demand for minimally invasive diagnostic procedures, is driving adoption of sentinel lymph node biopsy technologies.

Healthcare providers are increasingly implementing advanced imaging systems, radioactive tracers, fluorescence-guided technologies, and specialized surgical instruments to improve lymph node visualization and procedural accuracy.

Sentinel node biopsy technologies are increasingly used in:

• Breast cancer diagnosis and staging
• Melanoma management
• Oncology diagnostics
• Minimally invasive cancer surgery
• Lymph node mapping
• Image-guided surgical procedures
• Precision oncology
• Cancer treatment planning

The growing emphasis on early cancer detection, personalized treatment, shorter recovery periods, and reduced surgical complications is expected to support long-term market growth.

Key Market Trends Shaping Industry Growth

Rising Demand for Minimally Invasive Cancer Procedures

Healthcare providers are increasingly adopting sentinel node biopsy procedures because they can help determine lymph node involvement while reducing the need for extensive lymph node dissection. Growing preference for minimally invasive oncology procedures is supporting demand for advanced biopsy instruments and imaging technologies.

For detailed market insights, visit the Sentinel Node Biopsy Market Report:

https://www.fortunebusinessinsights.com/sentinel-node-biopsy-market-117620